Stay informed with the latest updates for the inheritable blood disorders community. IndustryFDA Gives Priority Review to Gilead's HCV Drug SofosbuvirJul 1, 2013 NBDF & CommunityNHF's Spring Soiree is a SuccessJul 1, 2013 NBDF & CommunityMASAC Issues Updated Treatment DocumentJul 1, 2013 NBDF & CommunityNHF Announces 2013 Excellence Fellowship RecipientsJun 1, 2013 Advocacy & LegislativePre-Existing Condition Insurance Plan Changes AnnouncedJun 1, 2013 Blood SafetyCanada Eases Restrictions on MSM Blood DonationsJun 1, 2013 IndustryFDA Accepts Application for Biogen's Longer-Lasting FVIII ProductJun 1, 2013 IndustryJanssen's HCV Therapy Receives FDA Priority ReviewJun 1, 2013 IndustryBayer Discontinues rFVIIa Therapy TrialJun 1, 2013 Advocacy & LegislativeACA Implementation Activity, NHF Advocacy ContinuesJun 1, 2013 IndustryAntiviral Oral Combination Treats Certain HCV PatientsMay 1, 2013 Advocacy & LegislativeAffordable Care Act Implementation ContinuesMay 1, 2013 IndustryAchillion Drug Begins Phase 2 Trial in HCV PatientsMay 1, 2013 IndustryGilead Announces HCV Drug Sofosbuvir Clinical Trial ResultsMay 1, 2013 Advocacy & LegislativePresident Releases 2014 Budget ProposalMay 1, 2013 Pagination First page Previous page … Page 76 Page 77 Page 78 Page 79 Current page 80 Page 81 Page 82 Page 83 Page 84 … Next page Last page
